​
​

Kintara Therapeutics (KTRA) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Kintara Therapeutics Revenue Highlights

0

Latest Revenue (Q)

$76.00K

Kintara Therapeutics Revenue by Period

Kintara Therapeutics Revenue by Year

DateRevenueChange
2024-06-30-100.00%
2023-06-30-100.00%
2022-06-30-100.00%
2021-06-30-100.00%
2020-06-30-100.00%
2019-06-30-100.00%
2018-06-30-100.00%
2017-06-30-100.00%
2016-06-30-100.00%
2015-06-30-100.00%
2014-06-30-100.00%
2012-12-31-100.00%
2012-06-30-100.00%
2011-06-30-100.00%
2010-06-30--

Kintara Therapeutics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

Kintara Therapeutics Revenue by Quarter

DateRevenueChange
2024-06-30$76.00K100.00%
2024-03-31-100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31-100.00%
2016-12-31-100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31-100.00%
2015-12-31-100.00%
2015-09-30-100.00%
2015-06-30-100.00%
2015-03-31-100.00%
2014-12-31-100.00%
2014-09-30-100.00%
2014-03-31-100.00%
2013-12-31-100.00%
2013-09-30-100.00%
2013-06-30-100.00%
2013-03-31-100.00%
2012-12-31-100.00%
2012-09-30-100.00%
2012-06-30-100.00%
2012-03-31-100.00%
2011-12-31-100.00%
2011-09-30-100.00%
2011-06-30-100.00%
2011-03-31-100.00%
2010-12-31-100.00%
2010-09-30-100.00%
2010-06-30-100.00%
2010-03-31-100.00%
2009-12-31--

Kintara Therapeutics generated $76.00K in revenue during Q4 2024, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

Kintara Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
MCRBSeres Therapeutics$126.33M-
SCPHscPharmaceuticals$13.59M$8.05M
FRTXFresh Tracks Therapeutics$8.01M-
BOLTBolt Biotherapeutics$7.88M$1.14M
KAKineta$5.44M-
DYAIDyadic$2.90M$1.96M
SABSSAB Biotherapeutics$2.24M$263.14K
LUMOLumos Pharma$2.05M$488.00K
MISTMilestone Pharmaceuticals$1.00M-
VCNXVaccinex$570.00K$52.00K
LIFEaTyr Pharma$353.00K$235.00K
TOVXTheriva Biologics--
FBRXForte Biosciences--
LSTALisata Therapeutics--
LBPHLongboard Pharmaceuticals--
DMACDiaMedica Therapeutics--
KTRAKintara Therapeutics-$76.00K
FWBIEntero Therapeutics--
CLRBCellectar Biosciences--
GOVXGeoVax Labs-$300.68K
ONCYOncolytics Biotech--
SLRXSalarius Pharmaceuticals--

KTRA Revenue FAQ

What is Kintara Therapeutics’s yearly revenue?

Kintara Therapeutics's yearly revenue for 2024 was $0, representing an increase of 100.00% compared to 2023. The company's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. KTRA's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021.

What is Kintara Therapeutics’s quarterly revenue?

Kintara Therapeutics's quarterly revenue for Q4 2024 was $76K, a 100.00% increase from the previous quarter (Q3 2024), and a 0% increase year-over-year (Q4 2023). The company's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). KTRA's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023).

What is Kintara Therapeutics’s revenue growth rate?

Kintara Therapeutics's revenue growth rate for the last 3 years (2022-2024) was 0%, and for the last 5 years (2020-2024) was 0%.